中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment

文献类型：期刊论文

作者Shi, Jia-jie1,2; Xing, Hui1,2; Wang, Yu-xiang1,2; Zhang, Xi1; Zhan, Qi-min3,4; Geng, Mei-yu2,5; Ding, Jian2,5; Meng, Ling-hua1,2
刊名CANCER LETTERS
出版日期2019
卷号459页码:145-155
关键词CYH33 Radiation Synergism ESCC PI3K alpha
ISSN号0304-3835
DOI10.1016/j.canlet.2019.05.040
通讯作者Ding, Jian(jding@simm.ac.cn) ; Meng, Ling-hua(lhmeng@simm.ac.cn)
英文摘要Radiotherapy is one of the standard therapies for esophageal squamous cell carcinoma (ESCC), but the efficacy is far from desirable. Large scale genome sequencing reveals PI3K alpha is frequently hyper-activated in ESCC. We found that ESCC cells harboring alterations in PI3K pathway were more resistant to radiation and combination of a clinical PI3K alpha-selective inhibitor CYH33 and radiation synergistically inhibited cell proliferation in 14 ESCC cell lines. Radiation induced phosphorylation of FOXO1 and Akt, which sensitized ESCC cells to PI3K alpha inhibitors. Both S1PR3 and DNA-PK contributed to radiation-induced Akt phosphorylation, which were revealed to be collectively dependent on PI3K alpha. By contrast, constitutively active Akt abrogated the synergism between PI3K alpha inhibitors and radiation. PI3K alpha inhibition enhanced radiation-induced DNA damage, G2/M arrest and apoptosis. Combination of CYH33 and radiation significantly inhibited the growth of xenografts derived from ESCC patients, which was accompanied with abrogation of radiation-induced phosphorylation of Akt and filtration of M2-like macrophages. Taken together, combination of CYH33 and radiation possesses synergism in ESCC, which provides promising rationale to test this combinatorial regimen in ESCC patients.
WOS关键词CANCER-CELLS ; HEAD ; NECK ; PI3K ; AKT ; MACROPHAGES ; RESISTANCE ; PARP
资助项目Personalized Medicines-Molecular Signature-based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020111] ; Personalized Medicines-Molecular Signature-based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020235] ; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program[2018ZX09711002-011-014] ; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program[2018ZX09711002-004-011] ; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program[2018ZX09711002-004-004] ; National Natural Science Foundation of China[81773760]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000480670800014
出版者ELSEVIER IRELAND LTD
源URL[http://119.78.100.183/handle/2S10ELR8/288940]  
专题新药研究国家重点实验室
通讯作者Ding, Jian; Meng, Ling-hua
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, 501 Halite Rd, Shanghai 201203, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China
4.Peking Union Med Coll, Beijing 100021, Peoples R China
5.Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714		 Shi, Jia-jie,Xing, Hui,Wang, Yu-xiang,et al. PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment[J]. CANCER LETTERS,2019,459:145-155.
APA Shi, Jia-jie.,Xing, Hui.,Wang, Yu-xiang.,Zhang, Xi.,Zhan, Qi-min.,...&Meng, Ling-hua.(2019).PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.CANCER LETTERS,459,145-155.
MLA Shi, Jia-jie,et al."PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment".CANCER LETTERS 459(2019):145-155.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。